HealthTree Logo
search more_vert
person Sign In / Create Account

Thomas Witzig, MD

DLBCL Specialist

location_city Mayo Clinic Rochester

38 years treating Diffuse Large B Cell Lymphoma

Clinical Expertise

  • Diffuse Large B Cell Lymphoma
  • Hodgkin lymphoma
  • Multiple myeloma
  • Non-Hodgkin's lymphoma


Thomas E. Witzig, M.D., has been a hematologist-oncologist for more than three decades, and has led a translational research laboratory since 1986. His research is focused on translational research in multiple myeloma and lymphoma.

Dr. Witzig's current focus is on the development of targeted agents for the treatment of malignant lymphoma. Specifically, his team is focusing on identifying the signaling pathways used by lymphoma cells to grow and survive, and on preclinical evaluation of agents to target those pathways.

Dr. Witzig has also contributed to many clinical trials, ranging from phase I to phase III. These trials include radioimmunotherapy, novel immunotherapy and chemotherapy agents, addition of novel agents to standard therapy, and translational research with biomarker analysis.


Mayo Clinic Rochester: Gonda Building, 200 1st St SW, Rochester, MN 55905, USA

Get the latest thought leadership on Extranodal Natural Killer delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Extranodal Natural Killer Newsletter" for Extranodal Natural Killer news, life with Extranodal Natural Killer stories, Extranodal Natural Killer clinical trials, Extranodal Natural Killer 101 articles and events with Extranodal Natural Killer experts.